Biohaven Ltd. (BHVN)
NYSE: BHVN
· Real-Time Price · USD
17.01
0.81 (5.00%)
At close: Jun 06, 2025, 3:59 PM
17.00
-0.06%
After-hours: Jun 06, 2025, 06:40 PM EDT
5.00% (1D)
Bid | 16.5 |
Market Cap | 1.74B |
Revenue (ttm) | n/a |
Net Income (ttm) | -888.6M |
EPS (ttm) | -9.25 |
PE Ratio (ttm) | -1.84 |
Forward PE | -2.6 |
Analyst | Buy |
Ask | 17.31 |
Volume | 1,252,176 |
Avg. Volume (20D) | 2,081,003.3 |
Open | 16.78 |
Previous Close | 16.20 |
Day's Range | 16.67 - 17.31 |
52-Week Range | 14.33 - 55.70 |
Beta | 3.64 |
About BHVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BHVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BHVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-19.53%
Biohaven shares are trading lower after the FDA's ...
Unlock content with
Pro Subscription
3 weeks ago
-5.11%
Biohaven shares are trading lower after the company reported a Q1 adjusted EPS miss.

3 days ago · accessnewswire.com
Levi & Korsinsky Investigating Whether Biohaven Ltd. (BHVN) Misled Investors - Securities Law Violations PossibleNEW YORK, NY / ACCESS Newswire / June 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biohaven Ltd. ("Biohaven Ltd.

3 days ago · accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven Ltd. - BHVNNEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Biohaven Ltd. ("Biohaven" or the "Company") (NYSE:BHVN).